세계의 AI 제어 관류 바이오리액터 시장 보고서(2025년)
Perfusion Bioreactor With Artificial Intelligence (AI) Control Global Market Report 2025
상품코드 : 1877842
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,693,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,675,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,656,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

AI 제어 관류 바이오리액터 시장 규모는 최근 급격히 확대되고 있습니다. 2024년 15억 5,000만 달러로 평가되었고, 2025년에는 18억 8,000만 달러, CAGR 21.3%로 성장할 전망입니다. 지난 몇 년간의 성장은 단일 청소년 생물반응기 도입 확대, 바이오의약품 연구개발 투자 증가, 효율적인 세포 배양 시스템 수요 증가, 연속 바이오프로세스 기법에 대한 주목이 높아지고, 제조 공정에서의 자동화 수준 향상 등이 요인으로 생각됩니다.

AI 제어 관류 바이오리액터 시장 규모는 향후 수년간 급격한 성장이 예상됩니다. 2029년에는 40억 2,000만 달러에 달하고, CAGR은 20.9%를 나타낼 전망입니다. 예측기간 중 성장요인으로는 디지털건강기술 채택 확대, 하이브리드형 바이오리액터 솔루션에 대한 선호도 증가, 고급 모니터링 시스템에 대한 수요 증가, 맞춤형 의료 분야에서의 응용 확대, 바이오프로세싱 혁신에 대한 정부 지원 강화 등이 있습니다. 예측기간 중 주요 동향으로는 인공지능 구동 제어 플랫폼의 기술적 진보, 연속 바이오프로세스 기법의 혁신, 자동화 감시·제어 시스템의 개발, 정밀의료 용도의 연구 개발, 디지털 제조 에코시스템과의 통합 등을 들 수 있습니다.

향후 수년간 AI 제어 관류 바이오리액터 시장의 성장은 맞춤형 의료의 보급 확대에 의해 견인될 것으로 예측됩니다. 맞춤형 의료는 보다 정확하고 효과적인 치료를 실현하기 위해 개인의 유전적, 분자적, 임상적 특성에 치료법을 적응시키는 의료 접근법입니다. 유전체학 기술의 진보로 환자의 유전자 프로파일에 근거한 치료법이 가능해지고, 유효성과 안전성이 향상됨으로써, 맞춤형 의료에 대한 수요가 높아지고 있습니다. AI 제어 관류 바이오리액터는 엄격하게 관리된 조건 하에서 줄기세포와 인공조직 등 환자 고유의 세포를 정밀하고 지속적으로 생산할 수 있게 함으로써 맞춤형 의료를 지원합니다. 예를 들어 미국에 본사를 둔 비영리 단체인 '맞춤형 의료연합'에 따르면 2024년 2월 시점에서 FDA는 2023년 희소질환 환자를 위한 신규 개인화 치료 16건을 승인했습니다. 이것은 2022년 6건에서 증가한 수치입니다. 이러한 신규 승인 치료에는 7유형의 암치료제와 기타 질환·증상에 대한 3유형의 치료법이 포함되어 있습니다. 따라서 맞춤형 의료의 보급 확대가 AI 제어 관류 바이오리액터 시장의 성장을 가속하고 있습니다.

AI 제어 관류 바이오리액터 시장의 주요 기업은 바이오의약품 제조에 있어서의 세포 배양 성능의 최적화, 제품 수율의 향상, 운용 비용의 삭감을 실현하기 위해 인공지능 강화형 실시간 바이오프로세스 모니터링 등 혁신적인 솔루션의 개발에 주력하고 있습니다. 인공지능 강화 실시간 바이오프로세스 모니터링은 인공지능 알고리즘을 사용하여 생물반응기 데이터를 지속적으로 분석하여 바이오 제조 공정에서 세포 성장과 제품 품질의 실시간 통찰, 예측 조정 및 최적화를 제공합니다. 예를 들어, 2025년 2월에는 독일에 본사를 둔 생명공학기업인 The Cultivated B GmbH가 세포 배양 및 발효 과정에 사용되는 생물반응기의 실시간 모니터링을 강화하기 위해 인공지능 구동 멀티채널 바이오센서를 도입했습니다. 이러한 바이오센서는 지속적인 고해상도 데이터 분석을 제공하여 바이오프로세스 엔지니어가 포도당, 아미노산, 락트산과 같은 분자를 서브피코몰 수준에서 고감도로 감지하면서 성장과 대사를 추적할 수 있게 합니다. 인공지능의 통합으로 배지 조성 최적화, 측정 정밀도 향상, 수동 샘플링 제거로 인한 오염 위험 최소화, 의약품, 생물학적 제제, 식품 생명공학, 폐기물 업사이클링, 대체 단백질 생산 분야에서 제품 개발 가속화를 위한 실시간 통찰과 권장사항을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

A perfusion bioreactor with artificial intelligence control is a bioreactor system designed for continuous cell culture that delivers fresh media and removes waste. Artificial intelligence monitors critical parameters and automatically adjusts conditions to optimize productivity, consistency, and efficiency in the manufacturing of biologics or cell-based products.

The main product types of perfusion bioreactors with artificial intelligence control include single-use perfusion bioreactors and multi-use perfusion bioreactors. Single-use perfusion bioreactors are disposable systems used for continuous cell culture that enhance scalability and minimize contamination risks in biomanufacturing. Artificial intelligence control features include predictive analytics, process optimization, real-time monitoring, automated feedback control, and others. These bioreactors are used in applications such as cell therapy, monoclonal antibody production, vaccine manufacturing, stem cell research, and others, and serve end users including biopharmaceutical companies, academic and research institutes, contract manufacturing organizations, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The perfusion bioreactor with artificial intelligence (AI) control market research report is one of a series of new reports from The Business Research Company that provides perfusion bioreactor with artificial intelligence (AI) control market statistics, including perfusion bioreactor with artificial intelligence (AI) control industry global market size, regional shares, competitors with a perfusion bioreactor with artificial intelligence (AI) control market share, detailed perfusion bioreactor with artificial intelligence (AI) control market segments, market trends and opportunities, and any further data you may need to thrive in the perfusion bioreactor with artificial intelligence (AI) control industry. This perfusion bioreactor with artificial intelligence (AI) control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The perfusion bioreactor with artificial intelligence (AI) control market size has grown exponentially in recent years. It will grow from $1.55 billion in 2024 to $1.88 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth during the historic period can be attributed to the rising adoption of single use bioreactors, the increasing investment in biopharmaceutical research and development, the growing demand for efficient cell culture systems, the expanding focus on continuous bioprocessing approaches, and the increasing level of automation in manufacturing processes.

The perfusion bioreactor with artificial intelligence (AI) control market size is expected to see exponential growth in the next few years. It will grow to $4.02 billion in 2029 at a compound annual growth rate (CAGR) of 20.9%. The growth during the forecast period can be attributed to the rising adoption of digital health technologies, the growing preference for hybrid bioreactor solutions, the increasing demand for advanced monitoring systems, the expanding applications in personalized medicine, and the growing government support for bioprocessing innovation. Major trends during the forecast period include technological advancements in artificial intelligence driven control platforms, innovations in continuous bioprocessing methods, developments in automated monitoring and control systems, research and development in precision medicine applications, and the integration with digital manufacturing ecosystems.

The increasing adoption of personalized medicine is expected to drive the growth of the perfusion bioreactor with artificial intelligence control market in the coming years. Personalized medicine is a medical approach that tailors treatment to an individual's genetic, molecular, and clinical characteristics for more accurate and effective care. The demand for personalized medicine is growing due to advances in genomics, which enable therapies customized to a patient's genetic profile for improved efficacy and safety. Perfusion bioreactors with artificial intelligence control support personalized medicine by enabling precise, continuous production of patient-specific cells, such as stem cells or engineered tissues, under tightly regulated conditions. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six approvals in 2022. These newly approved therapies included seven cancer drugs and three treatments for other diseases and conditions. Therefore, the growing adoption of personalized medicine is fueling the expansion of the perfusion bioreactor with artificial intelligence control market.

Leading companies in the perfusion bioreactor with artificial intelligence control market are focusing on developing innovative solutions such as artificial intelligence enhanced real-time bioprocess monitoring to optimize cell culture performance, improve product yield, and lower operational costs in biopharmaceutical manufacturing. Artificial intelligence enhanced real-time bioprocess monitoring involves the use of artificial intelligence algorithms to continuously analyze bioreactor data, providing real-time insights, predictive adjustments, and optimization of cell growth and product quality during biomanufacturing. For instance, in February 2025, The Cultivated B GmbH, a Germany-based biotechnology company, introduced artificial intelligence driven multi-channel biosensors to enhance real-time monitoring of bioreactors used in cell culture and fermentation processes. These biosensors provide continuous, high-resolution data analytics, enabling bioprocess engineers to track growth and metabolism with high sensitivity, detecting molecules at sub-picomolar levels such as glucose, amino acids, and lactic acid. The integration of artificial intelligence provides real-time insights and recommendations to optimize media formulation, enhance measurement accuracy, minimize contamination risk by removing manual sampling, and accelerate product development across pharmaceuticals, biologics, food biotechnology, waste upcycling, and alternative protein production.

In August 2025, Culture Biosciences Inc., a United States-based biotechnology company, partnered with Cytiva Bioscience Holding Ltd. to advance digital bioprocessing solutions. The partnership aims to accelerate and reduce risks in upstream bioprocess development by offering scalable, cloud-connected, and digitally integrated bioreactor systems that enable faster and more reliable therapeutic production from laboratory to commercial scale. Cytiva Bioscience Holding Ltd. is a United States-based biotechnology company that provides perfusion bioreactors with artificial intelligence control.

Major players in the perfusion bioreactor with artificial intelligence (ai) control market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG., Danaher Corporation, Sartorius Aktiengesellschaft, Getinge AB., WuXi Biologics Inc., Eppendorf Aktiengesellschaft, ABEC Inc., Catalyx.ai, PBS Biotech Inc., Cytovance Biologics, Culture Biosciences Inc., Esco Lifesciences Group Ltd., Cell Culture Company GmbH, Synthecon Inc., OmniBRx Biotechnologies Inc., ProlifeCell Inc., Sciperio Ltd., and The Cultivated B Ltd.

North America was the largest region in the perfusion bioreactor with artificial intelligence (AI) control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in perfusion bioreactor with artificial intelligence (AI) control report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the perfusion bioreactor with artificial intelligence (AI) control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The perfusion bioreactor with artificial intelligence (AI) control market consists of revenues earned by entities by providing services such as cell culture management, nutrient and waste regulation, AI-driven process control, performance optimization, and automated data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion bioreactor with artificial intelligence (AI) control market includes sales of automated perfusion bioreactor systems, hybrid perfusion bioreactors, and AI-integrated bench-scale perfusion bioreactors. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Perfusion Bioreactor With Artificial Intelligence (AI) Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on perfusion bioreactor with artificial intelligence (ai) control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for perfusion bioreactor with artificial intelligence (ai) control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The perfusion bioreactor with artificial intelligence (ai) control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Characteristics

3. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Trends And Strategies

4. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Growth Analysis And Strategic Analysis Framework

6. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Segmentation

7. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Regional And Country Analysis

8. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

9. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

10. India Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

11. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

12. Australia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

13. Indonesia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

14. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

15. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

16. UK Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

17. Germany Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

18. France Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

19. Italy Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

20. Spain Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

21. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

22. Russia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

23. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

24. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

25. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

26. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

27. Brazil Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

28. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

29. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

30. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Competitive Landscape And Company Profiles

31. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Other Major And Innovative Companies

32. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

34. Recent Developments In The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

35. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기